加利西亚普通人群家族性血脂异常患病率、脂质控制程度及其与动脉粥样硬化性心血管疾病的关系GALIPEMIAS研究。

IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE
José Luis Díaz-Díaz, M Eugenia Ameneiros, Rosa Argüeso Armesto, José María Mostaza Prieto, Xavier Pintó Sala, Avelino Rodríguez González, José Antonio Díaz-Peromingo, Alberto Del Alamo Alonso, Pablo Fernández Catalina, Manuel Suárez Tembra, Carlos Alberto Názara Otero, Marta Pena Seijo, Javier Muñiz García, Teresa Rosalía Pérez-Castro, Antonio Pose Reino, Juan Pedro-Botet Montoya
{"title":"加利西亚普通人群家族性血脂异常患病率、脂质控制程度及其与动脉粥样硬化性心血管疾病的关系GALIPEMIAS研究。","authors":"José Luis Díaz-Díaz, M Eugenia Ameneiros, Rosa Argüeso Armesto, José María Mostaza Prieto, Xavier Pintó Sala, Avelino Rodríguez González, José Antonio Díaz-Peromingo, Alberto Del Alamo Alonso, Pablo Fernández Catalina, Manuel Suárez Tembra, Carlos Alberto Názara Otero, Marta Pena Seijo, Javier Muñiz García, Teresa Rosalía Pérez-Castro, Antonio Pose Reino, Juan Pedro-Botet Montoya","doi":"10.1016/j.arteri.2025.500804","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>GALIPEMIAS is a study designed to determine the prevalence of familial dyslipidemias in the adult population of Galicia, evaluate the degree of lipid control according to the criteria of current clinical guidelines and analyze its association with atherosclerotic cardiovascular disease (ASCVD).</p><p><strong>Methods: </strong>Cross-sectional study carried out in the general population over 18years of age residing in Galicia and with a health card from the Galician Health Service (n=1,000). The sample was selected by random cluster sampling. The prevalence of familial combined hyperlipidemia (FCH), hypercholesterolemia with dominant inheritance pattern (HC-DI) and familial hypertriglyceridemia (FHTG), as well as suspected familial dysbetalipoproteinemia (FDB) and the joint prevalence of familial dyslipidemias with dominant inheritance (FDL-DI) were analyzed. For the assessment of cardiovascular risk (CVR), the criteria of the 2021 European guidelines for cardiovascular prevention were followed. The LDL-C control target required according to the CVR level was defined according to the 2019 European ESC/EAS guidelines.</p><p><strong>Results: </strong>The prevalence of FCH was 15.9% (95%CI: 13.6-18.4%), that of HC-DI 5.9% (95%CI: 4.5-7.6%), that of FHTG 1.7% (95%CI: 1.0-2.8%) and that of subjects with suspected FDB 0.9% (95%CI 0.4-1.6%). The joint prevalence of FDL-DI was 23.5% (95%CI: 20.8-26.3%), also present in 1 in 3 subjects with ASCVD. Overall, 60.5% of participants with FDL-DI had high or very high CV risk and 4.6% of them were on target for LDL-C control.</p><p><strong>Conclusions: </strong>The presence of familial dyslipidemia with dominant inheritance is the majority among the adult population living in Galicia with dyslipidemia, with FCH being the most prevalent of them. These subjects are underdiagnosed, are generally at high or very high cardiovascular risk, hardly receive lipid-lowering treatment (1 in 3) and the degree of LDL-C control according to guidelines is very poor. .</p>","PeriodicalId":45230,"journal":{"name":"Clinica e Investigacion en Arteriosclerosis","volume":" ","pages":"500804"},"PeriodicalIF":1.9000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of familial dyslipidemias, degree of lipid control and relationship with atherosclerotic cardiovascular disease in the general population of Galicia. GALIPEMIAS Study.\",\"authors\":\"José Luis Díaz-Díaz, M Eugenia Ameneiros, Rosa Argüeso Armesto, José María Mostaza Prieto, Xavier Pintó Sala, Avelino Rodríguez González, José Antonio Díaz-Peromingo, Alberto Del Alamo Alonso, Pablo Fernández Catalina, Manuel Suárez Tembra, Carlos Alberto Názara Otero, Marta Pena Seijo, Javier Muñiz García, Teresa Rosalía Pérez-Castro, Antonio Pose Reino, Juan Pedro-Botet Montoya\",\"doi\":\"10.1016/j.arteri.2025.500804\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>GALIPEMIAS is a study designed to determine the prevalence of familial dyslipidemias in the adult population of Galicia, evaluate the degree of lipid control according to the criteria of current clinical guidelines and analyze its association with atherosclerotic cardiovascular disease (ASCVD).</p><p><strong>Methods: </strong>Cross-sectional study carried out in the general population over 18years of age residing in Galicia and with a health card from the Galician Health Service (n=1,000). The sample was selected by random cluster sampling. The prevalence of familial combined hyperlipidemia (FCH), hypercholesterolemia with dominant inheritance pattern (HC-DI) and familial hypertriglyceridemia (FHTG), as well as suspected familial dysbetalipoproteinemia (FDB) and the joint prevalence of familial dyslipidemias with dominant inheritance (FDL-DI) were analyzed. For the assessment of cardiovascular risk (CVR), the criteria of the 2021 European guidelines for cardiovascular prevention were followed. The LDL-C control target required according to the CVR level was defined according to the 2019 European ESC/EAS guidelines.</p><p><strong>Results: </strong>The prevalence of FCH was 15.9% (95%CI: 13.6-18.4%), that of HC-DI 5.9% (95%CI: 4.5-7.6%), that of FHTG 1.7% (95%CI: 1.0-2.8%) and that of subjects with suspected FDB 0.9% (95%CI 0.4-1.6%). The joint prevalence of FDL-DI was 23.5% (95%CI: 20.8-26.3%), also present in 1 in 3 subjects with ASCVD. Overall, 60.5% of participants with FDL-DI had high or very high CV risk and 4.6% of them were on target for LDL-C control.</p><p><strong>Conclusions: </strong>The presence of familial dyslipidemia with dominant inheritance is the majority among the adult population living in Galicia with dyslipidemia, with FCH being the most prevalent of them. These subjects are underdiagnosed, are generally at high or very high cardiovascular risk, hardly receive lipid-lowering treatment (1 in 3) and the degree of LDL-C control according to guidelines is very poor. .</p>\",\"PeriodicalId\":45230,\"journal\":{\"name\":\"Clinica e Investigacion en Arteriosclerosis\",\"volume\":\" \",\"pages\":\"500804\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica e Investigacion en Arteriosclerosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.arteri.2025.500804\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Arteriosclerosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.arteri.2025.500804","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

目的:GALIPEMIAS是一项旨在确定加利西亚成年人群家族性血脂异常患病率的研究,根据现行临床指南的标准评估血脂控制程度,并分析其与动脉粥样硬化性心血管疾病(ASCVD)的相关性。方法:在加利西亚18岁以上、持有加利西亚保健服务卡的普通人群中进行横断面研究(n=1,000)。采用随机整群抽样的方法选取样本。分析家族性合并高脂血症(FCH)、显性遗传型高胆固醇血症(HC-DI)和家族性高甘油三酯血症(FHTG)的患病率,以及疑似家族性脂蛋白异常血症(FDB)和显性遗传型家族性血脂异常血症(FDL-DI)的联合患病率。对于心血管风险(CVR)的评估,遵循2021年欧洲心血管预防指南的标准。根据CVR水平所需的LDL-C控制目标根据2019年欧洲ESC/EAS指南定义。结果:FCH患病率为15.9% (95%CI: 13.6 ~ 18.4%), HC-DI患病率为5.9% (95%CI: 4.5 ~ 7.6%), FHTG患病率为1.7% (95%CI: 1.0 ~ 2.8%),疑似FDB患病率为0.9% (95%CI: 0.4 ~ 1.6%)。FDL-DI的联合患病率为23.5% (95%CI: 20.8-26.3%), ASCVD患者中也有1 / 3。总体而言,60.5%的FDL-DI患者有高或非常高的CV风险,其中4.6%的人达到了LDL-C控制的目标。结论:加利西亚成年血脂异常人群中以显性遗传的家族性血脂异常为主,其中以FCH最为常见。这些患者诊断不足,一般心血管风险高或极高,几乎没有接受降脂治疗(1 / 3),根据指南控制LDL-C的程度很差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prevalence of familial dyslipidemias, degree of lipid control and relationship with atherosclerotic cardiovascular disease in the general population of Galicia. GALIPEMIAS Study.

Objectives: GALIPEMIAS is a study designed to determine the prevalence of familial dyslipidemias in the adult population of Galicia, evaluate the degree of lipid control according to the criteria of current clinical guidelines and analyze its association with atherosclerotic cardiovascular disease (ASCVD).

Methods: Cross-sectional study carried out in the general population over 18years of age residing in Galicia and with a health card from the Galician Health Service (n=1,000). The sample was selected by random cluster sampling. The prevalence of familial combined hyperlipidemia (FCH), hypercholesterolemia with dominant inheritance pattern (HC-DI) and familial hypertriglyceridemia (FHTG), as well as suspected familial dysbetalipoproteinemia (FDB) and the joint prevalence of familial dyslipidemias with dominant inheritance (FDL-DI) were analyzed. For the assessment of cardiovascular risk (CVR), the criteria of the 2021 European guidelines for cardiovascular prevention were followed. The LDL-C control target required according to the CVR level was defined according to the 2019 European ESC/EAS guidelines.

Results: The prevalence of FCH was 15.9% (95%CI: 13.6-18.4%), that of HC-DI 5.9% (95%CI: 4.5-7.6%), that of FHTG 1.7% (95%CI: 1.0-2.8%) and that of subjects with suspected FDB 0.9% (95%CI 0.4-1.6%). The joint prevalence of FDL-DI was 23.5% (95%CI: 20.8-26.3%), also present in 1 in 3 subjects with ASCVD. Overall, 60.5% of participants with FDL-DI had high or very high CV risk and 4.6% of them were on target for LDL-C control.

Conclusions: The presence of familial dyslipidemia with dominant inheritance is the majority among the adult population living in Galicia with dyslipidemia, with FCH being the most prevalent of them. These subjects are underdiagnosed, are generally at high or very high cardiovascular risk, hardly receive lipid-lowering treatment (1 in 3) and the degree of LDL-C control according to guidelines is very poor. .

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinica e Investigacion en Arteriosclerosis
Clinica e Investigacion en Arteriosclerosis PERIPHERAL VASCULAR DISEASE-
CiteScore
3.20
自引率
6.20%
发文量
44
审稿时长
40 days
期刊介绍: La publicación idónea para acceder tanto a los últimos originales de investigación como a formación médica continuada sobre la arteriosclerosis y su etiología, epidemiología, fisiopatología, diagnóstico y tratamiento. Además, es la publicación oficial de la Sociedad Española de Arteriosclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信